LETS1 blocks the inhibitory effect of SMAD7 on TGFβR1 by increasing the expression of NR4A1, a protein involved in SMAD7 polyubiquitination and degradation, facilitating TGFβ-induced EMT and cellular migration in breast and lung cancer [116]. Here, SMAD7 is linked to lung carcinoma.